TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 15.00
-1.00 (-6.25%)
Sep 15, 2026, 1:58 PM CST
TaiRx Market Cap
TaiRx has a market cap or net worth of 832.08 million as of September 14, 2026. Its market cap has decreased by -74.98% in one year.
Market Cap
832.08M
Enterprise Value
101.66M
Revenue
29.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.00
ChartMarket Cap Chart
Since June 20, 2017, TaiRx's market cap has decreased from 3.25B to 832.08M, a decrease of -74.40%. That is a compound annual growth rate of -13.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 1.79B | -26.00% |
| Dec 31, 2025 | 2.42B | -15.03% |
| Dec 31, 2024 | 2.85B | 17.14% |
| Dec 29, 2023 | 2.44B | -27.90% |
| Dec 30, 2022 | 3.38B | -29.76% |
| Dec 30, 2021 | 4.81B | 86.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 1.83B |
| Andros Pharmaceuticals Co.,Ltd | 1.69B |
| Synbio Tech | 1.55B |
| Greenyn Biotechnology | 1.54B |
| Advagene Biopharma | 1.46B |
| U-Neuron Biomedical | 1.40B |
| GenMont Biotech Incorporation | 1.37B |
| NeoCore Technology | 1.27B |